Mr. Speaker, the CEO of Solstar Pharma wrote the innovation minister to say, “As far as Canada is concerned, we tried to move things forward, but to no avail. We were unable to secure the funding or key strategic partners in Canada that we needed to gain access to the labs.”
Canadian businesses are willing and able to get the job done. The fact that TriLink Bio Technologies, from San Diego, partnered very rapidly with Solstar is clear proof of that.
Why did the Prime Minister leave Solstar on the sidelines?